Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission

Malcolm Brenner; Robert Krance; Helen E. Heslop; Victor Santana; James Ihle; Raul Ribeiro; W. Mark Roberts; Hazem Mahmoud; James Boyett; Robert C. Moen; Hans G. Klingemann

doi:10.1089/hum.1994.5.4-481

Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission

Malcolm Brenner, Robert Krance, Helen E. Heslop, Victor Santana, James Ihle, Raul Ribeiro, W. Mark Roberts, Hazem Mahmoud, James Boyett, Robert C. Moen, Hans G. Klingemann

Research output: Contribution to journal › Article

22 Scopus citations

Original language	English (US)
Pages (from-to)	481-499
Number of pages	19
Journal	Human Gene Therapy
Volume	5
Issue number	4
DOIs	https://doi.org/10.1089/hum.1994.5.4-481
State	Published - Apr 1 1994

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/hum.1994.5.4-481

Cite this

Brenner, M., Krance, R., Heslop, H. E., Santana, V., Ihle, J., Ribeiro, R., Roberts, W. M., Mahmoud, H., Boyett, J., Moen, R. C., & Klingemann, H. G. (1994). Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission. Human Gene Therapy, 5(4), 481-499. https://doi.org/10.1089/hum.1994.5.4-481

Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission. / Brenner, Malcolm; Krance, Robert; Heslop, Helen E.; Santana, Victor; Ihle, James; Ribeiro, Raul; Roberts, W. Mark; Mahmoud, Hazem; Boyett, James; Moen, Robert C.; Klingemann, Hans G.

In: Human Gene Therapy, Vol. 5, No. 4, 01.04.1994, p. 481-499.

Research output: Contribution to journal › Article

Brenner, M, Krance, R, Heslop, HE, Santana, V, Ihle, J, Ribeiro, R, Roberts, WM, Mahmoud, H, Boyett, J, Moen, RC & Klingemann, HG 1994, 'Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission', Human Gene Therapy, vol. 5, no. 4, pp. 481-499. https://doi.org/10.1089/hum.1994.5.4-481

Brenner, Malcolm ; Krance, Robert ; Heslop, Helen E. ; Santana, Victor ; Ihle, James ; Ribeiro, Raul ; Roberts, W. Mark ; Mahmoud, Hazem ; Boyett, James ; Moen, Robert C. ; Klingemann, Hans G. / Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission. In: Human Gene Therapy. 1994 ; Vol. 5, No. 4. pp. 481-499.

@article{e7110e95c59e4c59a33cfd04820e4b67,

title = "Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission",

author = "Malcolm Brenner and Robert Krance and Heslop, {Helen E.} and Victor Santana and James Ihle and Raul Ribeiro and Roberts, {W. Mark} and Hazem Mahmoud and James Boyett and Moen, {Robert C.} and Klingemann, {Hans G.}",

year = "1994",

month = apr,

day = "1",

doi = "10.1089/hum.1994.5.4-481",

language = "English (US)",

volume = "5",

pages = "481--499",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "4",

}

TY - JOUR

T1 - Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission

AU - Brenner, Malcolm

AU - Krance, Robert

AU - Heslop, Helen E.

AU - Santana, Victor

AU - Ihle, James

AU - Ribeiro, Raul

AU - Roberts, W. Mark

AU - Mahmoud, Hazem

AU - Boyett, James

AU - Moen, Robert C.

AU - Klingemann, Hans G.

PY - 1994/4/1

Y1 - 1994/4/1

UR - http://www.scopus.com/inward/record.url?scp=0028070651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028070651&partnerID=8YFLogxK

U2 - 10.1089/hum.1994.5.4-481

DO - 10.1089/hum.1994.5.4-481

M3 - Article

C2 - 8049305

AN - SCOPUS:0028070651

VL - 5

SP - 481

EP - 499

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 4

ER -